The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 1, 1998, Pages 29-35

  Wiggenraad, Ruud ^a   Tamminga, Reinder ^a   Blok, Paul ^a   Rouse, Remigio ^a   Hermans, Jo ^b  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Local recurrence; p53; Radiotherapy; Rectal carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; RECTUM CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032054757     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00043-1     Document Type: Article

References (43)

1. Balslev I. B., Pedersen M., Teglbjaerg P. S., Hanberg-Soerensen F., Bone J., Jacobsen N. O., Overgaard J., Sell A., Bertelsen K., Hage E., Fenger C., Kronborg O., Hansen L., Hoestrup H., Noergaard-Pedersen B. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 58:1986;22-28.
2. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D. L., Fisher E. R., Caplan R., Jones J., Lerner H., Gordon P., Feldman M., Cruz A., Legault-Poisson S., Wexler M., Lawrence W., Robidoux A., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer Results from NSABP protocol R-01 . J. Natl. Cancer. Inst. 80:1988;21-29.
3. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med. 312:1985;1465-1472.
4. Hoskins R. B., Gunderson L. L., Dosoretz D. E., Rich T. A., Galdabini J., Donaldson G., Cohen A. M. Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Cancer. 55:1985;61-71.
5. Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Maillard J. A., Twito D. I., Morton R. F., Veeder M. H., Witzig T. E., Cha S., Vidyarthi S. C. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324:1991;709-715.
6. Tepper J. E., Cohen A. M., Wood W. C., Orlow E. L., Hedberg S. E. Postoperative radiation therapy of rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 13:1986;5-10.
7. Treurniet-Donker A. D., van Putten W. L. J., Wereldsma J. C. J., Bruggink E. D. M., Hoogenraad W. J., Roukema J. A., Snijders-Keilholz A., Meijer W. S., Meerwaldt J. H., Wijnmaalen A. J., Wiggers T. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in the Netherlands. Cancer. 67:1991;2042-2048.
8. Wiggenraad R., Raming M., Hermans J., Biesta J., Hoekstra F., de Jager-Nowak H. Postoperative local radiotherapy in rectal cancer Treatment results with limited radiation fields . Int. J. Radiat. Oncol. Biol. Phys. 27:1993;785-790.
9. Bristow R., Jang A., Peacock J., Chung S., Benchimol S., Hill R. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV 16-E7 and/or activated H-ras. Oncogene. 9:1994;1527-1536.
10. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
11. Zölzer F., Hillebrandt C., Streffer C. Radiation induced G1-block and p53 status in six human cell lines. Radiother. Oncol. 37:1995;20-28.
12. Auvinen A., Isola J., Visakorpi T., Koivula T., Virtanen S., Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br. J. Cancer. 70:1994;293-296.
13. Baretton G. B., Diebold J., Christoforis G., Vogt M., Müller Ch., Dopfer K., Schneiderbanger K., Schmidt M., Löhrs U. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer. 77:1996;255-264.
14. Bell S. M., Scott N., Cross D., Sagar P., Lewis F. A., Blair G. E., Taylor G. R., Dixon M. F., Quirke P. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 104:1993;57-64.
15. Bristow R., Benchimol S., Hill R. The p53 gene as a modifier of radiosensitivity implications for radiotherapy . Radiother. Oncol. 40:1996;197-223.
16. Campo E., Miquel R., Jares P., Bosch F., Juan M., Leone A., Vives J., Cardesa A., Yague J. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer. 73:1994;2913-2921.
17. Hamelin R., Laurent-Puig P., Olschwang S., Jego N., Asselain B., Remvikos Y., Girodet J., Salmon R. J., Thomas G. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology. 106:1994;42-48.
18. Laurent-Puig P., Olschwang S., Delattre O., Remvikos Y., Asselain B., Melot T., Validire P., Muleris M., Girodet J., Salmon R., Thomas G. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology. 102:1992;1136-1141.
19. Morrin M., Kelly M., Barrett N., Delaney P. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut. 35:1994;1627-1631.
20. Remvikos Y., Tominaga O., Hammel P., Laurent-Puig P., Salmon R. P., Dutrillaux B., Thomas G. Increased p53 protein content of colorectal tumors correlates with poor survival. Br. J. Cancer. 66:1992;758-764.
21. Scott N., Sagar P., Stewart J., Blair G. E., Dixon M. F., Quirke P. p53 in colorectal cancer Clinicopathological correlation and prognostic significance . Br. J. Cancer. 63:1991;317-319.
22. Starzynska T., Bromley M., Ghosh A., Stern P. L. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer. 66:1992;558-562.
23. Sun X. F., Carstensen J. M., Zhang H., Stal O., Wingren S., Hatschek T., Nordenskjöld B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet. 340:1992;1369-1373.
24. Yamaguchi A., Kurosaka Y., Fushida S., Kanno M., Yonemura Y., Miwa K., Miyazaki I. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer. 70:1992;2778-2784.
25. Yamaguchi A., Nakagawara G., Kurosaka Y., Nishimura G., Yonemura Y., Miyazaki I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br. J. Cancer. 68:1993;399-402.
26. Zeng Z., Sarkis A. S., Zhang Z., Klimstra D. S., Charytonowicz E., Guillem J. G., Cordon-Carda C., Cohen A. M. p53 Nuclear overexpression An independent predictor of survival in lymph node-positive colorectal cancer patients . J. Clin. Oncol. 12:1994;2043-2050.
27. Baas I. O., Mulder J. R., Offerhaus G. J. A., Vogelstein B., Hamilton S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 172:1994;5-12.
28. Bosari S., Viale G., Bossi P., Maggioni M., Coggi G., Murray J. J., Lee A. K. C. Cytoplasmic accumulation of p53 protein An independent prognostic indicator in colorectal adenocarcinomas . J. Natl. Cancer Inst. 86:1994;681-687.
29. Biard D. S. F., Martin M., Le Rhun Y., Duthu A., Lefaix L., May E., May P. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res. 54:1994;3361-3364.
30. Kawashima K., Mihara K., Usuki H., Shimizu N., Namba M. Transfected mutant p53 gene increases X-ray induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int. J. Cancer. 61:1995;76-79.
31. Servomaa K., Kiuru A., Grenman R., Pekkola-Heino K., Pulkkinen J., Rytomaa T. P53 mutations associated with incresed sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif. 29:1996;219-230.
32. Huang H., Li C., Little J. Abrogation of p53 function by transfection of HPV 16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. Int. J. Radiat. Biol. 70:1996;151-160.
33. Balcer-Kubiczek E., Yin J., Lin K., Harrison G., Abraham J., Meltzer S. P53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons. Radiat. Res. 142:1995;256-262.
34. Fan S., El-Deiry W., Bae I., Freeman J., Jondle D., Bhatia K., Fornace A., Magrath I., Kohn K., O'Connor P. P53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
35. Lee J., Bernstein A. P53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA. 90:1993;5742-5746.
36. McIlwrath A. J., Vasey P. A., Ross G. M., Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines Dependence on wild-type p53 for radiosensitivity . Cancer Res. 54:1994;3718-3722.
37. O'Connor P. M., Jackman J., Jondle D., Bhatia K., Magrath I., Kohn K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53:1993;4776-4780.
38. Pardo F., Su M., Borek C., Preffer F., Dombkowski D., Gerweck L., Schmidt E. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat. Res. 140:1994;180-185.
39. Siles E., Villalobos M., Nunez M., Gordon A., McMillan T., Pedraza V., Ruiz de Almodovar J. Relationship between p53 status and radiosensitivity in human tumor cell lines. Br. J. Cancer. 73:1996;581-588.
40. Awwad S., Jaros E., Somes J., Lunec. . P53 overexpression in head and neck carcinoma and radiotherapy results. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;323-332.
41. Langendijk J., Thunnissen F., de Lamers R., Jong J., ten Velde G., Wouters E. The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiother. Oncol. 36:1995;218-224.
42. Nakano T., Kuniyuki O., Taniguchi N. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res. 56:1996;2771-2775.
43. Wilson G., Richman P., Dische S., Saunders M., Robinson B., Daley F., Ross D. P53 status of head and neck cancer Relation to biological characteristics and outcome of radiotherapy . Br. J. Cancer. 71:1995;1248-1252.